Phosphoric Acid

Phosphoric Acid

SCHEMBL4435975

CCNC(=O)c1ccon1.O=P(O)(O)O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.41
ATM Q13315 1/20 0.40
ACACB O00763 1/20 0.40
RAB9A P51151 5/20 0.38
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37
MMP8 P22894 1/20 0.37
CHRNA4 P43681 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 3/20 0.37
GAA P10253 2/20 0.37
HPGD P15428 2/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
CYP2C19 P33261 1/20 0.36
HDAC4 P56524 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656888 0.95 ATM (0.43) CNR1ATMACACBRAB9ACHRNA4
SCHEMBL892942 0.83 ATM (0.40) ATMACACBRAB9ACHRNA4SMN1; SMN2
SCHEMBL19064377 0.81 RAB9A (0.54) ATMACACBRAB9ASMN1; SMN2NPC1
SCHEMBL893060 0.79 CHRNA4 (0.41) ATMACACBCHRNA4SMN1; SMN2GAA
SCHEMBL892675 0.78 ACACB (0.44) ATMACACBRAB9ACHRNA4SMN1; SMN2
SCHEMBL893320 0.78 ACACB (0.39) ATMACACBRAB9ACHRNA4SMN1; SMN2
SCHEMBL3940897 0.77 CHRNA4 (0.40) ATMACACBCHRNA4SMN1; SMN2GAA
SCHEMBL17883351 0.77 RAB9A (0.55) ACACBRAB9ASMN1; SMN2NPC1GAA
SCHEMBL26750156 0.77 ADORA2A (0.40) ATMACACBCHRNA4ALDH1A1AR
Hydrochloric Acid SCHEMBL3938535 0.76 CHRNA4 (0.39) ATMACACBCHRNA4SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2131845-A1 ACID ADDITION SALTS, HYDRATES AND POLYMORPHS OF 5-(2,4-DIHYDROXY-5-ISOPROPYL-PHENYL)-4-(4-MORPHOLIN-4-YLMETHYL-PHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYLAMIDE AND FORMULATIONS COMPRISING THESE FORMS Novartis AG (CH) 2009-12-16 EP disclosed
WO-2008104595-A1 ACID ADDITION SALTS, HYDRATES AND POLYMORPHS OF 5-(2,4-DIHYDROXY-5-ISOPROPYL-PHENYL)-4-(4-MORPHOLIN-4-YLMETHYL-PHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYLAMIDE AND FORMULATIONS COMPRISING THESE FORMS NOVARTIS AG (CH) 2008-09-04 WO disclosed